The Multidisciplinary Safety Net: Closing the Loop on Diagnostic Misclassification in Rare Salivary Gland Malignancies

Purpose: This report investigates the critical role of Multidisciplinary Tumor Boards (MTBs) and external pathology consultation as institutional safety nets. Specifically, we examine how these systems facilitate the "closing of the loop" when initial diagnostic pathways fail, particularly in the context of rare malignancies where misclassification can lead to significant delays in curative-intent therapy.

Methods/Materials: We performed a retrospective root-cause analysis of a 76 year old male’s six-year clinical journey. The primary focus was the systemic failure in 2019, where surgical pathology incorrectly identified a neck mass as a benign pleomorphic adenoma. We tracked the subsequent 2021 intervention where a Head and Neck Tumor Board triggered a "Gold Standard" re-evaluation. This process involved an external consultation with the Mayo Clinic, which successfully overturned the original diagnosis to poorly differentiated adenocarcinoma. We further analyzed the logistical leadership required to clear this high-risk patient, who presented with a large abdominal aortic aneurysm (AAA) and COPD, for aggressive surgical salvage.

Results: The MTB’s intervention effectively corrected a two-year diagnostic gap, shifting the patient’s trajectory from observation to a Modified Radical Neck Dissection (Levels I-IV). While the surgery confirmed a node-negative field (0/35), the delay necessitated high-dose adjuvant radiation (60Gy). The patient now faces the long-term "morbidity cost" of this salvage-intent therapy, including chronic cervicalgia, facial edema, and laryngeal whistling. These complications underscore the heavy burden placed on patients when early-stage diagnostic opportunities are missed.

Conclusions: High-reliability organizations in healthcare must rely on system redundancy rather than individual intuition. This case serves as a reminder that MTBs are not just for treatment planning, but are essential diagnostic filters. We propose that formal "re-review" protocols for all recurrent lesions initially deemed benign should be standard quality infrastructure to prevent the necessity of high-morbidity salvage interventions.